A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60–85 years old) and very elderly (>85 years old) institutionalized subjects

References

• Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K. Influenza-associated hospitalizations in the United States. JAMA. 2004;292(11):1333-40. doi:10.1001/jama.292.11.1333. PMID:15367555
   PubMed Web of Science ®Google Scholar
• Lang PO, Mendes A, Socquet J, Assir N, Govind S, Aspinall R. Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence. Clin Interv Aging. 2012;7:55-64. doi:10.2147/CIA.S25215. PMID:22393283
   PubMed Web of Science ®Google Scholar
• Govaert TM, Sprenger MJ, Dinant GJ, Aretz K, Masurel N, Knottnerus JA. Immune response to influenza vaccination of elderly people. A randomized double —blind placebo- controlled trial. Vaccine. 1994;12(13):1185-9. doi:10.1016/0264-410X(94)90241-0. PMID:7839722
   PubMed Web of Science ®Google Scholar
• Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006;24(8):1159-1169. doi:10.1016/j.vaccine.2005.08.105. PMID:16213065
   PubMed Web of Science ®Google Scholar
• Camilloni B, Nunzi E, Basileo M, Iorio AM. Antibody responses after influenza vaccination in elderly people: useful information from a 27-year study (from 1988—1989 to 2014—2015). Steps Forwards in Diagnosing and Controlling Influenza, Baddour M, Dr (Ed.). InTech, 2016
   Google Scholar
• People in the EU — statistics on an ageing society. Eurostat Statistics Explained. European Commission. Data extracted in June 2015 http://ec.europa.eu/eurostat/statisticsexplained/index.php/People_in_the_EU_%E2%80%93_statistics_on_an_ageing_society
   Google Scholar
• Camilloni B, Basileo M, Valente S, Nunzi E, Iorio AM. Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review. Hum Vaccin Immunother. 2015;11(3):553-63. doi:10.1080/21645515.2015.1011562. PMID:25714138
   PubMed Web of Science ®Google Scholar
• Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, et al. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine. 2008;26;Suppl 4:D31-4. doi:10.1016/j.vaccine.2008.07.078. PMID:19230156
   PubMed Web of Science ®Google Scholar
• Katz JM, Hancock K, Xu X. Serologic assay for influenza surveillance, diagnosis and vaccine evaluation. Expert Rev Anti Infect Ther. 2011;9(6):669-683. doi:10.1586/eri.11.51. PMID:21692672
   PubMed Web of Science ®Google Scholar
• Commission of the European Communities. Ad hoc working party on Biotechnology/Pharmacy. Harmonization of requirements for influenza vaccines. Document 111/3188/91-EN, Brussels. 1991
   Google Scholar
• Beyer WE, Palache AM, Lüchters G, Nauta J, Osterhaus AD. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? Virus Res. 2004;103(1—2):125-32. doi:10.1016/j.virusres.2004.02.024. PMID:15163500
   PubMed Web of Science ®Google Scholar
• Pyhala R, Kumpulainen V, Alanko S, Forsten T. HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990—1992. Vaccine. 1994;12(10);947-952. doi:10.1016/0264-410X(94)90039-6. PMID:7975836
   PubMed Web of Science ®Google Scholar
• de Bruijn IA, Remarque EJ, Jol-van der Zijde CM, van Tol MJ, Westendorp RG, Knook DL. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. J Infect Dis. 1999;179:31-36. doi:10.1086/314540. PMID:9841819
   PubMed Web of Science ®Google Scholar
• Targonski PV, Jacobson RM, Poland GA. Immunosenescence: Role and measurement in influenza vaccine response among the elderly. Vaccine. 2007;25:3066-3069. doi:10.1016/j.vaccine.2007.01.025. PMID:17275144
   PubMed Web of Science ®Google Scholar
• Chen WH, Kozlovsky BF, Effros RB, Grubeck-Loebenstein B, Edelman R, Sztein MB. Vaccination in the elderly: an immunological perspective. Trends Immunol. 2009;30(7):351-359. doi:10.1016/j.it.2009.05.002. PMID:19540808
   PubMed Web of Science ®Google Scholar
• Iorio AM, Alatri A, Camilloni B, Neri M, Baglio G, Donatelli I. Antibody response to 1995—1996 influenza vaccine in institutionalized and non-institutionalized elderly women. Gerontology. 1999;45:31-38. doi:10.1159/000022052. PMID:9852378
   PubMed Web of Science ®Google Scholar
• Mosterín Höpping A, McElhaney J, Fonville JM, Powers DC, Beyer WE, Smith DJ. The confounded effects of age and exposure history in response to influenza vaccination. Vaccine. 2016;34(4):540-6. doi:10.1016/j.vaccine.2015.11.058. PMID:26667611
   PubMed Web of Science ®Google Scholar
• Artz AS, Ershler VB, Longo DL. Pneumococcal vaccination and revaccination of older adults. Clin Microbiol Rev. 2003;16(2):308-318. doi:10.1128/CMR.16.2.308-318.2003. PMID:12692100
   PubMed Web of Science ®Google Scholar
• LeMaoult J, Szabo P, Weksler ME. Effect of age on humoral immunity, selection of the B-cell repertoire and B-cell development. Immunol Rev. 1997;160:115-26. doi:10.1111/j.1600-065X.1997.tb01032.x. PMID:9476670
   PubMed Web of Science ®Google Scholar
• Iorio AM, Camilloni B, Basileo M, Neri M, Lepri E, Spighi M. Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. Gerontology. 2007;53:411-418. doi:10.1159/000110579. PMID:17975317
   PubMed Web of Science ®Google Scholar
• Keitel WA, Cate TR, Couch RB, Huggins LL, Hess KR. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine. 1997;15:1114-1122. doi:10.1016/S0264-410X(97)00003-0. PMID:9269055
   PubMed Web of Science ®Google Scholar
• Nabeshima S, Kashiwagi K, Murata M, Kanamoto Y, Furusyo N, Hayashi J. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years. J Med Virol. 2007;79(3):320-325. doi:10.1002/jmv.20801. PMID:17245715
   PubMed Web of Science ®Google Scholar
• Ohmit SE, Petrie JC, Malosh RE, Cowling BJ, Thompson MG, Shay DK, Monto AS. Influenza vaccine effectiveness in the community and the household. Clin Infect Dis. 2013;56(10):1363-9. doi:10.1093/cid/cit060. PMID:23413420
   PubMed Web of Science ®Google Scholar
• Murasko DM, Bernstein ED, Gardner EM, Gross P, Munk G, Dran S, Abrutyn E. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol. 2002;37(2—3):427-439. doi:10.1016/S0531-5565(01)00210-8. PMID:11772530
   PubMed Web of Science ®Google Scholar
• Powers DC, Hanscome PJ, Pietrobon PJ. In previously immunized elderly adults inactivated influenza A(H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant. Vaccine. 1995;13(14):1330-1335. doi:10.1016/0264-410X(95)00002-I. PMID:8585289
   PubMed Web of Science ®Google Scholar
• Fonville JM, Wilks SH, James SL, Fox A, Ventresca M, Aban M, Xue L, Jones TC, Le NM, Pham QT, et al. Antibody landscapes after influenza virus infection or vaccination. Science 2014; 346:996-1000. doi:10.1126/science.1256427. PMID:25414313
   PubMed Web of Science ®Google Scholar
• O'Hagan DT. MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection. Expert Rev Vaccines. 2007;6:699-710. doi:10.1586/14760584.6.5.699. PMID:17931151
   PubMed Web of Science ®Google Scholar
• Arnou R, Icardi G, De Decker M, Ambrozaitis A, Kazek MP, Weber F, Van Damme P. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine. 2009;27:7304-12. doi:10.1016/j.vaccine.2009.10.033. PMID:19849996
   PubMed Web of Science ®Google Scholar
• Scheifele DW, McNeil SA, Ward BJ, Dionne M, Cooper C, Coleman B, Loeb M, Rubinstein E, McElhaney J, Hatchette T, et al. Safety, immunogenicity, and tolerability of three influenza vaccines in older adults. Hum Vaccines Immunotherapeutics. 2013;9:2460-73. doi:10.4161/hv.25580.
   PubMed Web of Science ®Google Scholar
• Basileo M, Iorio AM, Bartolini G, Bianchini C, Menculini G, Tozzi P, Camilloni B. Comparative study of immunogenicity of split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects. Procedia Vaccinol. 2014;8:18-23. doi:10.1016/j.provac.2014.07.004.
   Google Scholar
• Richardson DM, Medvedeva EL, Roberts CB, Linkin DR, Centers for Disease Control and Prevention Epicenter Program. Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans. Clin Infect Dis. 2015;61(2):171-6. doi:10.1093/cid/civ261. PMID:25829001
   PubMed Web of Science ®Google Scholar
• Harmon MW, editor. Influenza viruses. Laboratory diagnosis of viral infections. Second ed. New York: Edited by. Lennette EH, Dekker M; 1992:515-534
   Google Scholar